April 2023

Choosing the best biosimilar based on reimbursement can be challenging.

The gene-editing technology has been used successfully in a pediatric patient with T-cell ALL.

A panel of experts discuss how to define traditional vs nontraditional careers in oncology pharmacy.

Mosunetuzumab-axgb may be better tolerated by older adults with relapsed or refractory follicular lymphoma and patients with poor performance status.

Substantial strides have been made in the management of Ph+ ALL.

Major pathologic response had a high association with increased recurrence-free survival rates.

A standard chronological definition for older adults in oncology would be beneficial.

Remote services allow unrivaled opportunities for outreach to vulnerable populations and those in rural areas.

The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.

A strong theme of recent conferences was the push for greater awareness of pharmacists' roles in patient advocacy and patient education.

Some common questions for oncology pharmacists are about concurrent use of complementary and alternative medicine supplements and natural products.